Foster & Motley’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-6,727
Closed -$248K – 359
2023
Q2
$248K Sell
6,727
-680
-9% -$20.8K 0.02% 355
2023
Q1
$222K Sell
7,407
-167
-2% -$5.5K 0.02% 367
2022
Q4
$232K Buy
+7,574
New +$227K 0.02% 350
2022
Q3
– Sell
-7,953
Closed -$255K – 342
2022
Q2
$255K Sell
7,953
-423
-5% -$15.6K 0.02% 319
2022
Q1
$264K Sell
8,376
-349
-4% -$10.9K 0.02% 321
2021
Q4
$293K Buy
8,725
+1,192
+16% +$37.1K 0.02% 306
2021
Q3
$219K Buy
+7,533
New +$244K 0.02% 318

Other funds holding CC

Foster & Motley's CC Position: Q3 2023 in Review

Foster & Motley sold out of Chemours (CC) in Q3 2023, closing a stake of 6,727 shares — an estimated $248K sold.

Foster & Motley first reported a position in CC in Q3 2021 and held it in 7 quarters. The position peaked at $293K in Q4 2021. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Foster & Motley reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • Foster & Motley sold 6,727 Chemours shares in Q3 2023, an estimated $248K.
  • Foster & Motley first reported a position in Chemours in Q3 2021 and held it in 7 quarters.
  • Foster & Motley's Chemours position peaked at $293K in Q4 2021.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Foster & Motley's 13F filing for Q3 2023, filed 24 Oct 2023.